
Asarfi Hospital Board Approves AGM, Director Re-appointment, and BSE/NSE Migration
Asarfi Hospital Limited held a Board of Directors meeting on August 25, 2026. Key decisions included approving the Directors' Report for the year ended March 31, 2026, and the re-appointment of Director Mr. Gopal Singh. The Board also decided to convene the 21st Annual General Meeting (AGM) on September 18, 2026, setting September 5-18, 2026, for book closure and September 11, 2026, as the e-voting cut-off date. Furthermore, the company approved its migration from the BSE SME Platform to the BSE Main Board and proposed listing on NSE, subject to shareholder and regulatory approvals. The appointment of a Cost Auditor for FY 2026-27 and an authorized signatory for bidding processes were also approved.
Key Highlights
- Board approved Directors' Report for FY ended March 31, 2026.
- Mr. Gopal Singh re-appointed as Director.
- 21st AGM scheduled for September 18, 2026.
- Company to migrate from BSE SME to Main Board and list on NSE.
- Cost Auditor appointed for FY 2026-27.
Price Impact
More from ASARFI